Just a moment...

Top
FeedbackReport
×

By creating an account you can:

Logo TaxTMI
>
Feedback/Report an Error
Email :
Please provide your email address so we can follow up on your feedback.
Category :
Description :
Min 15 characters0/2000
Make Most of Text Search
  1. Checkout this video tutorial: How to search effectively on TaxTMI.
  2. Put words in double quotes for exact word search, eg: "income tax"
  3. Avoid noise words such as : 'and, of, the, a'
  4. Sort by Relevance to get the most relevant document.
  5. Press Enter to add multiple terms/multiple phrases, and then click on Search to Search.
  6. Text Search
  7. The system will try to fetch results that contains ALL your words.
  8. Once you add keywords, you'll see a new 'Search In' filter that makes your results even more precise.
  9. Text Search
Add to...
You have not created any category. Kindly create one to bookmark this item!
Create New Category
Hide
Title :
Description :
❮❮ Hide
Expand ❯❯
Close ✕
🔎 News - Adv. Search
    India 'bit recalcitrant' on trade negotiations: US Treasury Secy Bessent
    Stock markets climb in early trade as steady US inflation data fuel global rally
    Rupee falls 6 paise to 87.69 against US dollar in early trade
    Cabinet approves Investment Proposal for construction of 700 MW Tato-II Hydro Electric Project in Shi Yomi District of Arunachal Pradesh with an outla...
    PM Modi likely to visit New York for UNGA session next month
    US national debt reaches a record USD37 trillion, Treasury Department reports
    Trump administration calls out human rights records of some nations accepting deported migrants
    Sebi bans DHFL's Kapil Wadhawan, Dheeraj Wadhawan, 4 more from securities market
    Singaporean firm CapitaLand to invest Rs 9,200 crore in Maharashtra by 2030
    Two travellers held with hydroponic weed, another for wildlife smuggling bid at Mumbai airport
    Delhi govt seeking legal advice over SC's order of clearing power dues to discoms
    Aadhaar authentication to be done for issuing smart cards, passes for new govt buildings
    Suresh Raina to appear before ED on Aug 13 in illegal betting app case
    CM directs officials to ensure transparent, time-bound tender process for all civil works
    Amid protests against SC directive, Delhi govt says it will address street dog issue with empathy
    'Bengal means business,' says TMC MP
    ED conducts fresh searches in case against Sahara Group
    Railways' earnings showed 25.51-pc increase in 2022-23 over previous financial year: CAG
    Delhi Police allowed to make video depositions before court from stations
    Govt introduces insolvency law amendment bill in LS; FM says changes aim to reduce delays

Are you sure you want to delete "My most important" ?

NOTE:

News

Back

All News

Showing Results for : Category : All
Reset Filters
Showing
Records
ExpandCollapse

    News

    Back

    All News

    Showing Results for : Category : AllReset Filters
    Case ID :
    News and Press Release

    Gilead Briefs Nirmala Sitharaman about their Licensing Agreements with Seven India-Based Generic Pharmaceutical Manufacturers

    September 17, 2014

    📋
    Contents
    Summary
    Note

    Note

    Note

    Bookmark

    print

    Print

    A delegation of Gilead Sciences, Inc. met the Minister of State (Independent Charge) for Commerce and Industry Smt. Nirmala Sitharaman here yesterday. The delegation informed the Minister about signing of non–exclusive licensing agreements with seven India based generic pharmaceutical manufacturers allowing the companies - Cadila Healthcare Ltd., Cipla Ltd., Hetero Labs Ltd, Mylan Laboratories Ltd., Ranbaxy Laboratories Ltd., Sequent Scientific Ltd. and Strides Arcolab Ltd. - to manufacture Sofosbuvir and the investigational single tablet regimen of ledipasvir/sofosbuvir for distribution in 91 developing countries. These countries account for 54% of the total global infected population of Hepatitis C. The Gilead team also briefed the Minister about the fact that no price limitations have been fixed in the said licensing deal in order to ensure adequate competition amongst the licencees resulting in competitive prices for the patients.

    Smt Sitharaman welcomed the development as this will result in expansion of access of these drugs to many more patients. She emphasized that pharmaceutical industry has a very pronounced human aspect and such a sector cannot be governed by the commercial considerations alone. She also said that India respects the intellectual property in new drugs but also emphasized that complete technology transfer is important to enhance the country’s manufacturing capabilities in this critical area.

    The Minister further said that India appreciates the value of innovation and partnerships to improve access of medicines through transparent, non restrictive voluntary licensing and hope that it will help in technology transfer in front-end technologies in healthcare.

    The delegation informed the Minister that under the licensing agreements, the Indian companies receive a technology transfer of the Gilead manufacturing process to enable them to scale up production as quickly as possible.

    Topics

    ActsIncome Tax